AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
GB9616237D0
(en)
*
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
GB9902689D0
(en)
*
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
DE19921693A1
(de)
*
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US7214687B2
(en)
|
1999-07-14 |
2007-05-08 |
Almirall Ag |
Quinuclidine derivatives and medicinal compositions containing the same
|
ES2165768B1
(es)
*
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
PE20010720A1
(es)
*
|
1999-12-11 |
2001-07-26 |
Glaxo Group Ltd |
Distribuidor de medicamento
|
US6651655B1
(en)
*
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
GB0008660D0
(en)
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
CZ303833B6
(cs)
*
|
2000-05-22 |
2013-05-22 |
Chiesi Farmaceutici S.P.A. |
Aerosolový prostredek
|
US20060257324A1
(en)
*
|
2000-05-22 |
2006-11-16 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical solution formulations for pressurised metered dose inhalers
|
FR2812545B1
(fr)
*
|
2000-08-03 |
2003-03-28 |
Air Liquide Sante Int |
Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
|
US20040081627A1
(en)
*
|
2000-10-09 |
2004-04-29 |
Jinks Phillip A |
Medicinal aerosol formulations
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
GEP20063905B
(en)
*
|
2000-10-12 |
2006-08-25 |
Boehringer Ingelheim Pharma |
Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
|
US6620438B2
(en)
*
|
2001-03-08 |
2003-09-16 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
|
US20020137764A1
(en)
|
2000-10-31 |
2002-09-26 |
Karin Drechsel |
Inhalable formulation of a solution containing a tiotropium salt
|
BR0115016A
(pt)
*
|
2000-10-31 |
2005-05-03 |
Boehringer Ingelheim Pharma |
Formulação de solução inalativa com um sal de tiotrópio
|
US7776315B2
(en)
*
|
2000-10-31 |
2010-08-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and additional active ingredients
|
US20100310477A1
(en)
*
|
2000-11-28 |
2010-12-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Pharmaceutical compositions based on anticholingerics and additional active ingredients
|
DE10111843A1
(de)
*
|
2001-03-13 |
2002-09-19 |
Boehringer Ingelheim Pharma |
Verbindungen zur Behandlung von inflammatorischen Erkrankungen
|
ATE375142T1
(de)
*
|
2001-03-30 |
2007-10-15 |
Jagotec Ag |
Medizinische aerosolformulierungen
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
US20030013675A1
(en)
*
|
2001-05-25 |
2003-01-16 |
Boehringer Ingelheim Pharma Kg |
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
|
US6472563B1
(en)
*
|
2001-11-09 |
2002-10-29 |
Sepracor Inc. |
Formoterol tartrate process and polymorph
|
US6858615B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenyl guanidine sodium channel blockers
|
ES2779273T3
(es)
*
|
2002-03-01 |
2020-08-14 |
Chiesi Farm Spa |
Formulación superfina de formoterol
|
DE10212264A1
(de)
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
|
DE10214263A1
(de)
*
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
|
US7244415B2
(en)
|
2002-03-28 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations of an anhydrate
|
US7311894B2
(en)
*
|
2002-03-28 |
2007-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations containing an anticholinergic
|
DE10214264A1
(de)
*
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen eines Anhydrats
|
GB0207906D0
(en)
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and mometasone aerosol formulations
|
GB0207899D0
(en)
*
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and cielesonide aerosol formulations
|
KR20050045946A
(ko)
|
2002-06-25 |
2005-05-17 |
애크럭스 디디에스 피티와이 리미티드 |
비정질 약학적 조성물을 이용한 경피전달속도의 제어
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
CA2507572C
(en)
*
|
2002-12-10 |
2011-04-19 |
Sepracor Inc. |
Levalbuterol salt
|
EP1572217B1
(en)
*
|
2002-12-12 |
2008-08-20 |
Nycomed GmbH |
Combination medicament of r,r-formoterol and ciclesonide
|
US20050058606A1
(en)
*
|
2002-12-16 |
2005-03-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing HFC solution formulations
|
US20040152720A1
(en)
*
|
2002-12-20 |
2004-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
|
CN1292748C
(zh)
*
|
2003-03-05 |
2007-01-03 |
南昌弘益科技有限公司 |
噻托溴铵吸入粉雾剂及其制备工艺
|
AU2004224367B2
(en)
*
|
2003-03-20 |
2009-10-08 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
|
US20060293293A1
(en)
*
|
2003-05-22 |
2006-12-28 |
Altana Pharma Ag |
Salmeterol and ciclesonide combination
|
GB0312148D0
(en)
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
US8435497B2
(en)
|
2003-06-13 |
2013-05-07 |
Takeda Gmbh |
Formoterol of and ciclesonide combination
|
GB0315889D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Aventis Pharma Ltd |
Stable pharmaceutical products
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
US20050026948A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
AU2003254429A1
(en)
*
|
2003-08-06 |
2005-02-25 |
Galephar M/F |
Advantageous combinations for inhalation of nacystelyn and bronchodilators
|
US7745442B2
(en)
|
2003-08-20 |
2010-06-29 |
Parion Sciences, Inc. |
Methods of reducing risk of infection from pathogens
|
PL1670482T5
(pl)
*
|
2003-09-16 |
2022-10-03 |
Covis Pharma Gmbh |
Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
|
EP1699435A4
(en)
*
|
2003-09-18 |
2009-05-20 |
Norton Healthcare Ltd |
PARTICLE
|
GB0323684D0
(en)
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
GB0323685D0
(en)
*
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
NZ548302A
(en)
*
|
2004-02-06 |
2010-04-30 |
Meda Pharma Gmbh & Co Kg |
Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
|
EP1713471B1
(en)
*
|
2004-02-06 |
2012-01-18 |
MEDA Pharma GmbH & Co. KG |
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
|
CN100569235C
(zh)
*
|
2004-02-06 |
2009-12-16 |
Meda制药有限及两合公司 |
用于哮喘和copd长期治疗的抗胆碱能药和糖皮质激素的组合
|
EP1595531A1
(en)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
EP1720577A2
(en)
*
|
2004-02-27 |
2006-11-15 |
Altana Pharma AG |
Ciclesonide and glycopyrronium combination
|
JP2007533706A
(ja)
*
|
2004-04-20 |
2007-11-22 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
|
US20050238632A1
(en)
*
|
2004-04-23 |
2005-10-27 |
Alburty David S |
Propellant formulations
|
AU2013201437B2
(en)
*
|
2004-04-23 |
2015-09-03 |
Cydex Pharmaceuticals, Inc |
DPI formulation containing sulfoalkyl ether cyclodextrin
|
CA2562585A1
(en)
*
|
2004-04-23 |
2005-11-10 |
Cydex, Inc. |
Dpi formulation containing sulfoalkyl ether cyclodextrin
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
ITRM20040268A1
(it)
*
|
2004-05-31 |
2004-08-31 |
Italchimici S P A |
Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
|
EA013428B1
(ru)
*
|
2004-07-02 |
2010-04-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
|
ATE520390T1
(de)
|
2004-12-27 |
2011-09-15 |
Beiersdorf Ag |
Glycopyrrolat in kosmetischen zubereitungen
|
JP3955868B2
(ja)
*
|
2004-12-27 |
2007-08-08 |
株式会社キングジム |
書類等の綴じ具
|
DE102005029390A1
(de)
*
|
2005-06-23 |
2007-01-04 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Glycopyrroniumbromid und Polyolen
|
GB0501956D0
(en)
*
|
2005-01-31 |
2005-03-09 |
Arrow Internat |
Nebulizer formulation
|
JP4991693B2
(ja)
*
|
2005-03-16 |
2012-08-01 |
メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
呼吸器疾患の治療のための抗コリン作用薬及びロイコトリエン受容体アンタゴニストの組み合わせ剤
|
US20060239935A1
(en)
*
|
2005-04-23 |
2006-10-26 |
Boehringer Ingelheim International Gmbh |
Compositions for inhalation
|
JP2008538758A
(ja)
*
|
2005-04-23 |
2008-11-06 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物
|
AU2006243238B2
(en)
|
2005-05-02 |
2012-05-24 |
Boehringer Ingelheim International Gmbh |
Novel crystalline forms of tiotropium bromide
|
CN101212975A
(zh)
|
2005-06-03 |
2008-07-02 |
艾克若克斯Dds有限公司 |
用于透皮给药的方法和组合物
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
ES2330047T3
(es)
|
2005-12-21 |
2009-12-03 |
MEDA PHARMA GMBH & CO. KG |
Combinacion de r,r-glicopirrolato, rolipram y budesonida para el tratmiento de enfermedades inflamatorias.
|
AU2012200449B2
(en)
*
|
2005-12-21 |
2013-07-25 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
DE102006017320A1
(de)
*
|
2006-04-11 |
2007-10-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
|
ES2298049B1
(es)
*
|
2006-07-21 |
2009-10-20 |
Laboratorios Almirall S.A. |
Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
|
AU2007333302A1
(en)
*
|
2006-12-07 |
2008-06-19 |
Eli Lilly And Company |
An article comprising prasugrel
|
DE102007002121B4
(de)
*
|
2007-01-10 |
2008-12-11 |
Dräger, Karl-Heinz |
Verwendung eines Flüssiggasgemisches als nichtbrennbares Treibgas zum Feinstverteilen eines Reiz- oder Kampfstoffes
|
CA2608561A1
(en)
*
|
2007-10-29 |
2009-04-29 |
Carl Paluszkiewicz |
Motorcycle wind deflector accessory support
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
US20110132357A1
(en)
|
2009-05-29 |
2011-06-09 |
Pearl Therapeutics, Inc. |
Compositions, methods & systems for respiratory delivery of two or more active agents
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
TR200907237A2
(tr)
*
|
2009-09-23 |
2011-04-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum kuru toz kombinasyonu
|
GB0918149D0
(en)
*
|
2009-10-16 |
2009-12-02 |
Jagotec Ag |
Improved medicinal aerosol formulation
|
TR200907914A2
(tr)
*
|
2009-10-20 |
2011-05-23 |
Bi̇lgi̇ç Mahmut |
Kortlkosteroid içeren kuru toz formunda farmasötik bileşim.
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
EP2515854B1
(en)
|
2009-12-23 |
2014-03-19 |
Chiesi Farmaceutici S.p.A. |
Aerosol formualtion for COPD
|
RU2561052C2
(ru)
*
|
2009-12-23 |
2015-08-20 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Комбинированное лечение хронического обструктивного заболевания легких
|
EA021917B1
(ru)
|
2009-12-23 |
2015-09-30 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Комбинированная терапия астмы и copd
|
TR200909792A2
(tr)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
|
TR200909790A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, formoterol ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
|
TR200909789A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, budesonid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
|
TR200909791A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Salmeterol ve flutikazon içeren farmasötik bileşim@
|
TR200909793A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, mometazon ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
|
US8834931B2
(en)
|
2009-12-25 |
2014-09-16 |
Mahmut Bilgic |
Dry powder formulation containing tiotropium for inhalation
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
GB201108039D0
(en)
|
2011-05-13 |
2011-06-29 |
Mexichem Amanco Holding Sa |
Compositions
|
EP2721036B1
(en)
|
2011-06-15 |
2015-07-22 |
Takeda GmbH |
Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
|
MX2013014888A
(es)
|
2011-06-17 |
2014-02-27 |
Takeda Gmbh |
Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida.
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
GB201117619D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
GB201117621D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
MX2015007797A
(es)
|
2012-12-17 |
2015-10-05 |
Parion Sciences Inc |
Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida.
|
WO2014099676A1
(en)
|
2012-12-17 |
2014-06-26 |
Parion Sciences, Inc. |
Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
|
WO2014113638A1
(en)
*
|
2013-01-17 |
2014-07-24 |
Aer Devices, Inc. |
Multi-use albuterol maintenance therapy formulations and devices therefor
|
EP2968152B2
(en)
|
2013-03-15 |
2022-06-22 |
Pearl Therapeutics, Inc. |
Methods and systems for conditioning of particulate crystalline materials
|
GB201306984D0
(en)
|
2013-04-17 |
2013-05-29 |
Mexichem Amanco Holding Sa |
Composition
|
US9102633B2
(en)
|
2013-12-13 |
2015-08-11 |
Parion Sciences, Inc. |
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
|
MX368835B
(es)
|
2013-12-30 |
2019-10-18 |
Chiesi Farm Spa |
Composición combinada de bromuro de glicopirronio y formoterol en solución estable presurizada para aerosol.
|
PT3104853T
(pt)
|
2014-02-10 |
2020-01-14 |
Respivant Sciences Gmbh |
Tratamento com estabilizadores de mastócitos para distúrbios sistémicos
|
HUE049323T2
(hu)
|
2014-02-10 |
2020-09-28 |
Respivant Sciences Gmbh |
Hízósejt-stabilizálók tüdõbetegség kezelésére
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
EP3331522A1
(en)
|
2015-08-07 |
2018-06-13 |
Patara Pharma LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
ES2796177T3
(es)
|
2015-12-04 |
2020-11-26 |
Mexichem Fluor Sa De Cv |
Composición farmacéutica
|
AU2017321495A1
(en)
|
2016-08-31 |
2019-03-21 |
Respivant Sciences Gmbh |
Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
|
JP6781830B2
(ja)
|
2016-09-19 |
2020-11-04 |
メキシケム フロー エセ・ア・デ・セ・ヴェ |
医薬組成物
|
AU2017328907B2
(en)
*
|
2016-09-19 |
2020-04-09 |
Mexichem Fluor S.A. De C.V. |
Pharmaceutical composition
|
JP6781828B2
(ja)
|
2016-09-19 |
2020-11-04 |
メキシケム フロー エセ・ア・デ・セ・ヴェ |
医薬組成物
|
EP3522983A4
(en)
|
2016-10-07 |
2020-06-03 |
Respivant Sciences GmbH |
CROMOLYNE-BASED COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
|
WO2018069210A1
(en)
|
2016-10-10 |
2018-04-19 |
Takeda Gmbh |
Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
|
EA201990605A1
(ru)
*
|
2016-10-14 |
2019-10-31 |
|
Распыляемые композиции тиотропия и формотерола
|
WO2020031148A1
(en)
*
|
2018-08-10 |
2020-02-13 |
Tykhonivska Nataliya |
Pharmaceutical composition, medicinal product and method of treatment of bronchopulmonary obstructive diseases
|
KR20220108047A
(ko)
|
2019-12-02 |
2022-08-02 |
키에시 파르마슈티시 엣스. 피. 에이. |
가압 정량 흡입기를 위한 스테인리스 스틸 캔
|
CN112972384B
(zh)
*
|
2019-12-02 |
2022-03-18 |
长风药业股份有限公司 |
一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法
|
WO2023227781A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|
WO2023227783A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|
WO2023227782A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|